Literature DB >> 31237466

RNA Helicase LGP2 Negatively Regulates RIG-I Signaling by Preventing TRIM25-Mediated Caspase Activation and Recruitment Domain Ubiquitination.

Kendra M Quicke1,2, Kristin Y Kim1,2, Curt M Horvath3, Mehul S Suthar1,2.   

Abstract

The retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) are a family of cytosolic pattern recognition receptors that play a critical role in binding viral RNA and triggering antiviral immune responses. The RLR LGP2 (or DHX58) is a known regulator of the RIG-I signaling pathway; however, the underlying mechanism by which LGP2 regulates RIG-I signaling is poorly understood. To better understand the effects of LGP2 on RIG-I-specific signaling and myeloid cell responses, we probed RIG-I signaling using a highly specific RIG-I agonist to compare transcriptional profiles between WT and Dhx58-/- C57BL\6 bone marrow-derived dendritic cells. Dhx58-/- cells exhibited a marked increase in the magnitude and kinetics of type I interferon (IFN) induction and a broader antiviral response as early as 1 h post-treatment. We determined that LGP2 inhibited RIG-I-mediated IFN-β, IRF-3, and NF-κB promoter activities, indicating a function upstream of the RLR adaptor protein mitochondrial antiviral signaling. Mutational analysis of LGP2 revealed that RNA binding, ATP hydrolysis, and the C-terminal domain fragment were dispensable for inhibiting RIG-I signaling. Using mass spectrometry, we discovered that LGP2 interacted with the E3 ubiquitin ligase TRIM25. Finally, we determined that LGP2 inhibited the TRIM25-mediated K63-specific ubiquitination of the RIG-I N-terminus required for signaling activation.

Entities:  

Keywords:  LGP2; RIG-I-like receptors; TRIM25; ubiquitination

Year:  2019        PMID: 31237466      PMCID: PMC6820871          DOI: 10.1089/jir.2019.0059

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  41 in total

1.  Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2.

Authors:  Darja Bamming; Curt M Horvath
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

2.  The Stat3/5 locus encodes novel endoplasmic reticulum and helicase-like proteins that are preferentially expressed in normal and neoplastic mammary tissue.

Authors:  Y Cui; M Li; K D Walton; K Sun; J A Hanover; P A Furth; L Hennighausen
Journal:  Genomics       Date:  2001-12       Impact factor: 5.736

3.  Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses.

Authors:  Thiagarajan Venkataraman; Maikel Valdes; Rachel Elsby; Shigeru Kakuta; Gisela Caceres; Shinobu Saijo; Yoichiro Iwakura; Glen N Barber
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

4.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.

Authors:  Michaela U Gack; Young C Shin; Chul-Hyun Joo; Tomohiko Urano; Chengyu Liang; Lijun Sun; Osamu Takeuchi; Shizuo Akira; Zhijian Chen; Satoshi Inoue; Jae U Jung
Journal:  Nature       Date:  2007-04-19       Impact factor: 49.962

5.  Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Authors:  Yueh-Ming Loo; Jamie Fornek; Nanette Crochet; Gagan Bajwa; Olivia Perwitasari; Luis Martinez-Sobrido; Shizuo Akira; Michelle A Gill; Adolfo García-Sastre; Michael G Katze; Michael Gale
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

6.  Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response.

Authors:  David Olagnier; Florine E M Scholte; Cindy Chiang; Irina C Albulescu; Carmen Nichols; Zhong He; Rongtuan Lin; Eric J Snijder; Martijn J van Hemert; John Hiscott
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

7.  A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant.

Authors:  L Martínez-Gil; P H Goff; R Hai; A García-Sastre; M L Shaw; P Palese
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

8.  Functional interactions between ubiquitin E2 enzymes and TRIM proteins.

Authors:  Luisa M Napolitano; Ellis G Jaffray; Ronald T Hay; Germana Meroni
Journal:  Biochem J       Date:  2011-03-01       Impact factor: 3.857

9.  Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.

Authors:  Gretja Schnell; Yueh-Ming Loo; Joseph Marcotrigiano; Michael Gale
Journal:  PLoS Pathog       Date:  2012-08-02       Impact factor: 6.823

Review 10.  Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule.

Authors:  Michael B A Oldstone; Hugh Rosen
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

View more
  11 in total

Review 1.  Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity.

Authors:  GuanQun Liu; Michaela U Gack
Journal:  Immunity       Date:  2020-07-14       Impact factor: 31.745

2.  Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors.

Authors:  Katharina Esser-Nobis; Lauren D Hatfield; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

3.  Immune regulator LGP2 targets Ubc13/UBE2N to mediate widespread interference with K63 polyubiquitination and NF-κB activation.

Authors:  Jessica J Lenoir; Jean-Patrick Parisien; Curt M Horvath
Journal:  Cell Rep       Date:  2021-12-28       Impact factor: 9.423

4.  Decoding the vital segments in human ATP-dependent RNA helicase.

Authors:  Vandana Kamjula; Ananya Kanneganti; Rohan Metla; Kusuma Nidamanuri; Sudarshan Idupulapati; Ashish Runthala
Journal:  Bioinformation       Date:  2020-02-29

Review 5.  Virus-Host Interactions in Foot-and-Mouth Disease Virus Infection.

Authors:  Kangli Li; Congcong Wang; Fan Yang; Weijun Cao; Zixiang Zhu; Haixue Zheng
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

6.  Chicken-Derived Pattern Recognition Receptor chLGP2 Inhibits the Replication and Proliferation of Infectious Bronchitis Virus.

Authors:  Kailu Wang; Pengfei Cui; Ruiqi Ni; Huiling Gong; Hao Li; Wenjun Yan; Xue Fu; Liang Chen; Changwei Lei; Hongning Wang; Xin Yang
Journal:  Front Microbiol       Date:  2022-01-25       Impact factor: 5.640

Review 7.  Cytoplasmic RNA sensors and their interplay with RNA-binding partners in innate antiviral response: theme and variations.

Authors:  Chi-Ping Chan; Dong-Yan Jin
Journal:  RNA       Date:  2022-01-14       Impact factor: 4.942

8.  Duck LGP2 Downregulates RIG-I Signaling Pathway-Mediated Innate Immunity Against Tembusu Virus.

Authors:  Tianxu Li; Yanyan Ren; Tingting Zhang; Xinyu Zhai; Xiuyuan Wang; Jinchao Wang; Bin Xing; Runchun Miao; Ning Li; Liangmeng Wei
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

9.  LGP2 is essential for zebrafish survival through dual regulation of IFN antiviral response.

Authors:  Xiu-Ying Gong; Qi-Min Zhang; Xiang Zhao; Yi-Lin Li; Zi-Ling Qu; Zhi Li; Cheng Dan; Jian-Fang Gui; Yi-Bing Zhang
Journal:  iScience       Date:  2022-07-30

Review 10.  Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.

Authors:  Katarzyna Wicherska-Pawłowska; Tomasz Wróbel; Justyna Rybka
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.